Delivery Order SPE2DB22D3004-SPE2DB24FRA10
Award Date
7/10/24
Potential Completion Date
7/11/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Tresiba FlexTouch 100 unit/mL 3mL insulin pens. The $2,001.06 firm fixed-price delivery order is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to deliver a wide range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,162.44 firm fixed-price contract is for the delivery of Tresiba FlexTouch 200 unit/ml 3ml insulin pens, with a period of performance through July 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Tresiba FlexTouch insulin pens, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,484.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 27, 2024, with a completion date of November 29, 2024. The contract is not designated as a set-aside and represents a direct procurement under AmerisourceBergen's existing Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4558479310 units of Tresiba FlexTouch insulin pens. The $2,376.48 firm fixed-price delivery order has a completion date of September 16, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $5,867.68 firm-fixed-price delivery order is for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The award does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. The $3,002.58 Firm Fixed Price delivery order was awarded on April 21, 2022 with an ultimate completion date of April 22, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 31, 2024. The $1,656.60 firm fixed-price delivery order is for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $4,128.52 firm-fixed-price delivery order contract (SPE2DB22D3004|SPE2DB24FRN07) for the supply of Tresiba FlexTouch 200 Unit/mL 3mL insulin pens. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a range of medical commodities...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for $2,001.55 to supply Tresiba Flextouch 200 unit/mL 3mL insulin pens. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Tresiba Flextouch 200 Unit/mL 3mL insulin injector pens. The $108,791.54 firm fixed-price delivery order contract has a period of performance through May 16, 2023 and was awarded on May 15, 2023. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the...